Rhumbline Advisers Insulet Corp Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Insulet Corp stock. As of the latest transaction made, Rhumbline Advisers holds 144,989 shares of PODD stock, worth $37.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

144,989

Previous 146,561 1.07%

Holding current value

$37.7 Million

Previous $29.6 Million 14.1%

% of portfolio

0.03%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$180.69 - $239.01 $284,044 - $375,723	-1,572 Reduced 1.07%	144,989 $33.7 Million
Q2 2024 Aug 01, 2024	BUY	$161.02 - $206.98 $121,892 - $156,683	757 Added 0.52%	146,561 $29.6 Million
Q1 2024 May 09, 2024	BUY	$163.6 - $209.11 $116,810 - $149,304	714 Added 0.49%	145,804 $25 Million
Q4 2023 Feb 08, 2024	SELL	$127.77 - $221.42 $48,552 - $84,139	-380 Reduced 0.26%	145,090 $31.5 Million
Q3 2023 Nov 09, 2023	SELL	$154.67 - $290.89 $523,557 - $984,662	-3,385 Reduced 2.27%	145,470 $23.2 Million
Q2 2023 Aug 08, 2023	SELL	$272.48 - $330.23 $741,690 - $898,886	-2,722 Reduced 1.8%	148,855 $42.9 Million
Q1 2023 May 11, 2023	BUY	$276.36 - $326.03 $18.5 Million - $21.8 Million	66,814 Added 78.82%	151,577 $48.3 Million
Q4 2022 Feb 14, 2023	BUY	$212.22 - $313.46 $918,700 - $1.36 Million	4,329 Added 5.38%	84,763 $25 Million
Q3 2022 Nov 10, 2022	BUY	$224.6 - $281.45 $708,613 - $887,974	3,155 Added 4.08%	80,434 $18.5 Million
Q2 2022 Aug 11, 2022	BUY	$186.4 - $279.02 $1.69 Million - $2.53 Million	9,065 Added 13.29%	77,279 $16.8 Million
Q1 2022 May 12, 2022	SELL	$194.8 - $275.7 $645,567 - $913,669	-3,314 Reduced 4.63%	68,214 $18.2 Million
Q4 2021 Feb 10, 2022	BUY	$255.32 - $318.29 $384,001 - $478,708	1,504 Added 2.15%	71,528 $19 Million
Q3 2021 Nov 12, 2021	SELL	$260.36 - $307.27 $134,085 - $158,244	-515 Reduced 0.73%	70,024 $19.9 Million
Q2 2021 Aug 05, 2021	SELL	$225.52 - $304.06 $934,103 - $1.26 Million	-4,142 Reduced 5.55%	70,539 $19.4 Million
Q1 2021 May 06, 2021	SELL	$235.95 - $293.05 $747,725 - $928,675	-3,169 Reduced 4.07%	74,681 $19.5 Million
Q4 2020 Feb 10, 2021	SELL	$215.97 - $265.89 $556,338 - $684,932	-2,576 Reduced 3.2%	77,850 $19.9 Million
Q3 2020 Nov 12, 2020	SELL	$192.55 - $236.59 $459,231 - $564,267	-2,385 Reduced 2.88%	80,426 $19 Million
Q2 2020 Aug 13, 2020	BUY	$159.17 - $224.73 $2.84 Million - $4.01 Million	17,858 Added 27.49%	82,811 $16.1 Million
Q1 2020 May 06, 2020	SELL	$130.01 - $216.44 $88,536 - $147,395	-681 Reduced 1.04%	64,953 $10.8 Million
Q4 2019 Feb 05, 2020	BUY	$144.81 - $186.0 $241,543 - $310,248	1,668 Added 2.61%	65,634 $11.2 Million
Q3 2019 Oct 23, 2019	SELL	$117.35 - $167.95 $34,148 - $48,873	-291 Reduced 0.45%	63,966 $10.6 Million
Q2 2019 Aug 14, 2019	SELL	$82.13 - $120.73 $430,689 - $633,108	-5,244 Reduced 7.55%	64,257 $7.67 Million
Q1 2019 May 01, 2019	SELL	$72.44 - $101.87 $4,418 - $6,214	-61 Reduced 0.09%	69,501 $6.61 Million
Q4 2018 Jan 31, 2019	SELL	$73.27 - $105.19 $190,355 - $273,283	-2,598 Reduced 3.6%	69,562 $5.52 Million
Q3 2018 Nov 07, 2018	SELL	$81.43 - $108.13 $107,813 - $143,164	-1,324 Reduced 1.8%	72,160 $7.65 Million
Q2 2018 Aug 06, 2018	BUY	$83.27 - $101.93 $522,852 - $640,018	6,279 Added 9.34%	73,484 $6.3 Million
Q1 2018 May 02, 2018	SELL	$68.49 - $87.2 $134,034 - $170,650	-1,957 Reduced 2.83%	67,205 $5.83 Million
Q4 2017 Feb 09, 2018	SELL	$55.67 - $71.8 $549,908 - $709,240	-9,878 Reduced 12.5%	69,162 $4.77 Million
Q3 2017 Nov 06, 2017	BUY	$49.68 - $59.46 $3.93 Million - $4.7 Million	79,040	79,040 $4.35 Million

Others Institutions Holding PODD

# of Institutions

685

Shares Held

62.7M

Call Options Held

640K

Put Options Held

881K

View Full List

About INSULET CORP

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

More about PODD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Insulet Corp Transaction History